Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
十六烷氧基丙基替诺福韦（CMX157）的开发用于治疗由野生型和核苷/核苷酸耐药性 HIV 引起的感染
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00068-10
Lanier E Randall, Ptak Roger G, Lampert Bernhard M, Keilholz Laurie, Hartman Tracy, Buckheit Robert W Jr, Mankowski Marie K, Osterling Mark C, Almond Merrick R, Painter George R
